NCT01660581View on ClinicalTrials.gov

Intracardiac CD133+ Cells in Patients With No-option Resistant Angina

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Stable Angina
Interventions
BIOLOGICAL

intramyocardial injection (electromechanical mapping based)

Patient will undergo 3D electric and mechanical intracardiac mapping; based on maps generated intramyocardial administration of autologous CD133+ cells or placebo will be performed.

BIOLOGICAL

Placebo

Patients in the placebo group receive 0.9% NaCl solution with 0.5% solution of the patient's own serum.

Trial Locations (1)

40-635

Samodzielny Publiczny Szpital Kliniczny nr 7 Śląskiego Uniwersytetu Medycznego w Katowicach Górnośląskie Centrum Medyczne im. prof. Leszka Gieca, Katowice-Ochojec

All Listed Sponsors
lead

Medical University of Silesia

OTHER

NCT01660581 - Intracardiac CD133+ Cells in Patients With No-option Resistant Angina | Biotech Hunter | Biotech Hunter